Related Experiment Videos
The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action
M A Parry1, C Fernandez-Catalan, A Bergner
1Max-Planck Institute of Biochemistry, Department for Structural Research, Martinsried, Germany. parry@biochem.mpg.de
Abstract:
The serine proteinase plasmin is the key fibrinolytic enzyme that dissolves blood clots and also promotes cell migration and tissue remodeling. Here, we report the 2.65 A crystal structure of a ternary complex of microplasmin-staphylokinase bound to a second microplasmin. The staphylokinase 'cofactor' does not affect the active-site geometry of the plasmin 'enzyme', but instead modifies its subsite specificity by providing additional docking sites for enhanced presentation of the plasminogen 'substrate' to the 'enzymes's' active site. The activation loop of the plasmin 'substrate', cleaved in these crystals, can be reconstructed to show how it runs across the active site of the plasmin 'enzyme' prior to activation cleavage. This is the first experimental structure of a productive proteinase-cofactor-macromolecular substrate complex. Furthermore, it provides a template for the design of improved plasminogen activators and plasmin inhibitors with considerable therapeutical potential.
Insights
This study reveals the crystal structure of microplasmin-staphylokinase bound to microplasmin, detailing how staphylokinase enhances plasminogen activation for clot dissolution. This finding aids in designing better plasminogen activators and inhibitors.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Medicine
Background:
- Plasmin is a key fibrinolytic enzyme crucial for dissolving blood clots.
- Plasmin also plays roles in cell migration and tissue remodeling.
- Understanding plasmin-enzyme interactions is vital for therapeutic development.
Purpose of the Study:
- To determine the crystal structure of a ternary complex involving microplasmin, staphylokinase, and a second microplasmin molecule.
- To elucidate the mechanism by which staphylokinase acts as a cofactor in plasminogen activation.
- To provide a structural basis for designing improved plasminogen activators and inhibitors.
Main Methods:
- X-ray crystallography was used to determine the structure of the ternary complex at 2.65 A resolution.
- Analysis of the crystal structure focused on the interactions between microplasmin, staphylokinase, and plasminogen.
- Computational reconstruction of the plasminogen activation loop was performed.
Main Results:
- The crystal structure of a productive proteinase-cofactor-macromolecular substrate complex was determined for the first time.
- Staphylokinase, acting as a cofactor, enhances plasminogen presentation to the plasmin active site without altering active-site geometry.
- The structure reveals how the plasminogen activation loop interacts with the plasmin active site prior to cleavage.
Conclusions:
- The staphylokinase cofactor modifies plasmin's subsite specificity, facilitating efficient plasminogen activation.
- The elucidated structure serves as a template for designing novel therapeutic agents targeting the fibrinolytic system.
- This research holds significant potential for developing improved treatments for thrombotic disorders and other conditions involving plasmin activity.